Table 3. Clinical response 6 weeks after initiation of the treatment.

	No response	Partial improvement	Complete healing	Total
ILMA * (% [95% CI†])	26 (65.0 [49.5–77.9])	9 (22.5 [12.3–37.5])	5 (12.5 [5.5–26.1])	40 (100)
ILMA + non-silver dressing (% [95% CI])	37 (80.4) [66.8–89.3]	6 (13.0 [6.1–25.7])	3 (6.5 [2.2–17.5])	46 (100)
ILMA + silver dressing (% [95% CI])	41 (74.6 [61.7–84.2])	7 (12.7 [6.3–24.0])	7 (12.7 [6.3–24])	55 (100)
Total (%[95% CI])	104 (73.8 [65.9–80.3])	22 (15.6 [10.5–22.5])	15 (10.6 [6.6–16.8])	141 (100)

^*ILMA  =  intralesioinal meglumine antimoniate. † 95% Confidence Interval.